ICD-10 Coding for Endometrial Adenocarcinoma(C54.1)
Complete ICD-10-CM coding and documentation guide for Endometrial Adenocarcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Endometrial Adenocarcinoma
C54-C55Primary Range
Malignant neoplasms of corpus uteri
This range includes codes for malignant neoplasms of the endometrium, which is the primary site for endometrial adenocarcinoma.
Other noninflammatory disorders of female genital tract
This range includes codes for conditions that may be associated with or lead to the diagnosis of endometrial adenocarcinoma, such as cervical stenosis and postmenopausal bleeding.
Key Information: ICD-10 code for endometrial adenocarcinoma
Essential facts and insights about Endometrial Adenocarcinoma
Primary ICD-10-CM Code for endometrial adenocarcinoma
Decision Criteria
clinical Criteria
- Histopathological confirmation of endometrial adenocarcinoma
documentation Criteria
- Detailed pathology report specifying histologic type and grade
Applicable To
- Endometrial adenocarcinoma
Excludes
- Endocervical adenocarcinoma (C53.9)
Clinical Validation Requirements
- Histopathological confirmation of endometrial adenocarcinoma
- Imaging studies showing endometrial thickening
Code-Specific Risks
- Misclassification with other uterine neoplasms
Coding Notes
- Ensure histological confirmation before coding.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Cervical stenosis
N88.2Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Malignant neoplasm of cervix, unspecified
C53.9Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Endometrial Adenocarcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C54.1.
Impact
Clinical: Impacts treatment decisions and prognosis estimation., Regulatory: Non-compliance with cancer registry reporting standards., Financial: Potential for incorrect DRG assignment.
Mitigation Strategy
Use standardized reporting templates, Ensure complete pathology report review
Impact
Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Potential for audit discrepancies., Data Quality: Inaccurate cancer registry data.
Mitigation Strategy
Always specify 'endometrial' origin in pathology reports.
Impact
Lack of specificity in histologic documentation can lead to audit findings.
Mitigation Strategy
Use detailed synoptic reporting for all pathology findings.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Endometrial Adenocarcinoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Endometrial Adenocarcinoma
Use these documentation templates to ensure complete and accurate documentation for Endometrial Adenocarcinoma. These templates include all required elements for proper coding and billing.
Postmenopausal bleeding with biopsy-confirmed adenocarcinoma
Specialty: Gynecologic OncologyRequired Elements
- Patient history
- Biopsy results
- Molecular testing results
- Treatment plan
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Endometrial Adenocarcinoma? Ask your questions below.